Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (Text with EEA relevance. )
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 54, Propineb, the date is replaced by β31 January 2019β; (2) in the sixth column, expiration of approval, of row 55, Propyzamide, the date is replaced by β31 January 2019β; (3) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by β31 January 2019β; (4) in the sixth column, expiration of approval, of row 58, Propiconazole, the date is replaced by β31 January 2019β; (5) in the sixth column, expiration of approval, of row 77, Zoxamide, the date is replaced by β31 January 2019β; (6) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by β31 January 2019β; (7) in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by β31 January 2019β; (8) in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by β31 January 2019β; (9) in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by β31 January 2019β; (10) in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by β31 January 2019β; (11) in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by β31 January 2019β; (12) in the sixth column, expiration of approval, of row 121, Clothianidin, the date is replaced by β31 January 2019β; (13) in the sixth column, expiration of approval, of row 122, Pethoxamid, the date is replaced by β31 January 2019β; (14) in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by β31 January 2019β; (15) in the sixth column, expiration of approval, of row 277, Copper compounds, the date is replaced by β31 January 2019β.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.